Subject: Something About Chemtrails. Part 3, June 27, 2006.
Let's hope the good type ETs come down and stop these
Chemtrails. It's sort of like the old joke about the
golf ball landing on an ant hill. The golfer struck
at the ball but missed and wiped out a hundred ants.
This was repeated several times until there were only
2 ants left. One ant said to the other ant, "The only
way we're going to get out of here alive, is get on the
ball.
.............................................................
.............................................................
What is to be gleaned from the preceding point is that
govern-ents worldwide are involved in aggressively
spraying the population with agents that have biological
effects. They are in a hurry, considering their frequency
and density of coverage, as if a deadline is to be met.
The project has risked discovery by employing commercial
airlines to help with the spraying, and such a risk can
only be justified if the project itself were in the nature
of an emergency. They have also risked their sec-ecy by
spraying during the day to affect as many people as
possible, when all below can plainly see these contrails
are anything but.
What worldwide emergency could be of such im****tance
and threat to the world gov-rnments?
Piece 2: Bacterially Induced Transcession and Gene
Therapy via Vector Viruses.
This section concerns altering one's DNA via
incor****ation of foreign DNA from bacteria or viruses.
First Clue that Viruses Affect Host's DNA
The term 'transcession' appears in a Leading Edge
article, quoted as follows:
"One of the indications that vaccinations may in fact
be changing the genetic structure of humans became evident
in September of 1971, when scientists at the University
of Gen-va made the discovery that biological substances
entering directly into the bloodstream could become part
of human genetic structure. In one experiment, scientists
in Gene-a extracted the auricles of frog hearts and dipped
them for several hours in a suspension of bacteria.
Afterward, they found a high percentage of RNA-DNA
hybridization between bacterial DNA extracted from
bacteria of the same species as that used in the
experiment and titrated DNA extracted from the auricles
which had been dipped in the bacterial suspension.
Bacterial DNA had been absorbed by the animal cells.
This phenomenon has been dubbed transcession. There is
evidence that this kind of phenomenon is happening all
the time within the human body. It is conceivable, for
example, that heart damage following rheumatic fever
could the the result of the immune system reacting to
its own cells producing a foreign RNA complex after
absorption of foreign DNA." (link)
For those interested in the transcession capability
of vaccines, consider this quote about gene therapy:
"Yet another technique is to simply inject ****d DNA. This
approach wouldn't work well as direct injection into the
bloodstream because the body's DNA degrading enzymes
would quickly digest it. But some experiments have shown
that when ****d DNA is injected directly into muscle
tissue [as in a vaccine injection], say, the cells start
producing whatever proteins the DNA codes for. (from
this link on gene therapy)
In other words, transcession is the process whereby
bacterial DNA becomes part of a host cell's DNA. The
term transcession is more commonly known as transduction,
or conjugation, more generally termed horizontal gene
transfer. Horizontal means between species, as opposed
to vertical which is from parent to offspring.
Gene Therapy Employs Viruses to Alter Host DNA
This is one way how gene therapy, which seeks to correct
genetic diseases, works. Visit this animation for a short
tutorial on how viruses are used in gene therapy.
Here's another excerpt from an article confirming the
use of viruses in gene therapy: "To turn viruses into
gene ferries, scientists have developed ways of stripping
the genes out of a virus and substituting copies of the
genes they want to transfer into cells. The virus is then
mixed with cells taken out of the body that are then
returned. Or they can be injected directly into the body
itself, homing in on the cells of interest. Retroviruses,
which insert their genetic code directly into the
chromosomes of the host cell, have been used a lot because
of their ability to break into chromosomes and insert the
DNA. Other viruses are now also being used. One of the big
drawbacks of viruses is that the immune system can't tell
the difference between bad viruses and those that carry a
beneficial gene. So, many of the viruses are rapidly wiped
out [that is, of course, unless the immune system is
weakened by other chemical/biological agents such that
these viruses survive long enough to transduce their DNA
into the host]." (link)
Methods of Applying Gene Therapy via Virus Vectors to
Patients
Non-invasive methods of gene therapy are already well
established. A team at the Thomas Jeff-rson University
in Philadelphia accomplished just that using an oral
method of gene therapy:
Dr. During and his colleagues inserted a
beta-galactosidase gene--which encodes for an enzyme that
breaks down lactose--into an adeno-associated virus vector.
They then gave this orally through a special tube to
lactose-intolerant rats. The gene incor****ated into the
cells lining the rats' gastrointestinal tract, allowing
them to break down lactose.
"We showed several im****tant things," he says. "We could
deliver a gene noninvasively, we could achieve long-term
gene expression through a simple oral route, and there was
enough gene expression to treat a disease such as lactose
intolerance." (link)
Even madsci.org has something to say about these
non-invasive methods:
Gene therapy is one of the most interesting and valuable
techniques to come out of the field of genetic engineering.
The adenovirus used to deliver the CF gene to human cells
for gene therapy is known as a vector. Since most cells
normally will not take in or absorb DNA, we need a delivery
system to get the gene into the cell. Adenovirus is a good
vector since it can infect cells in vivo, or while they're
in the body, which means that the gene can be delivered
through an inhaler (instead of having to manipulate the
cells in vitro, or in the laboratory, then return the
cells to the body). To use the adenovirus as a vector, it's
genome was first altered by removing all the virus DNA
except for the minimum necessary for the virus to live
and infect the cells. Genetically engineered viral vectors
like this are harmless and usually can't live outside of
the laboratory. (link)
But some virus vectors are not without drawbacks:
All viral approaches suffer from the drawback of
introducing unwanted viral genetic information into the
recipient host. Retroviral vectors and adenoviruses have
additional disadvantages. Retroviruses are only suitable
for delivery of DNA to replicating cells, and present a
risk of reversion to replication competent infective
particles, whilst DNA expression using adenovirus delivery
systems tends to be short lived [thus the repeated
chemtrail sprayings over the past two years in the same
geographic areas and the use of a host of vectors to
ensure success when one fails] (link).
Later in the article, one solution to the problem is
proposed:
"...Novel vectors for gene therapy are therefore needed
which avoid the potential risks of using viral material,
but can stably transfer exogenous DNA to target cells, to
sites and at levels that produce a therapeutic effect.
A novel vector with potential for use in gene therapy
has been developed by Professor Beverly Gri-fin and
colleagues in the Department of Infe-tious Diseases at
the Ham-ersmith Hospital Campus of Imper-al College(1).
Her team has shown that pseudocapsids of the mouse
polyoma virus, consisting solely of the VP1 protein, can
be used to transfer DNA into mammalian cells in vivo, to
give expression at clinically-relevant levels over a
period of weeks.
Polyoma virus has a very broad host range which means
that the pseudocapsids will be taken up by essentially
any human or other mammalian cell. Development and
selection of mutant VP1 proteins, together with
engineered specific labels may enable cell-specific
targeting for in vivo applications. Pseudocapsids
completely free of viral genetic material can be
produced easily and economically.
Polyoma pseudocapsids can successfully transfer up to
7.2 Kb of DNA and research is investigating the
production of oversized pseudocapsids. These oversized
capsids would enable transfer of much larger amounts of
genetic material than is currently possible with adeno
or retrovirus vectors. "
In other words, technology already exists allowing
virus vectors to effectively alter the DNA of a host's
cell. This is not science fiction. One company among
many, A-A Technology, is presently researching and
selling aerosol (most likely inhaler, but expandable
to atmospheric) products for use in gene therapy.
Part 3.
John Winston. johnfw@[EMAIL PROTECTED]
|
